TiGenix NV

Datum

29/12/2017

Categorie

TransactionOPA

Sector

OPA

Files

2017-(123)-FR-NL-EN-OPA20171230-A14-B01-C01-NP-CD29_12.xls

Supplements

Document type	Transaction date	File
Prospectus	27/04/2018	2018-(123)-EN-OPA20171230-A14-B01-C01-NP-CD26_04.PDF
Kennisgeving FSMA of mededeling bieder	30/12/2017	2017-(123)-FR-NL-EN-OPA20171230-A14-B01-C01-NP-CD29_12.pdf
Kennisgeving FSMA of mededeling bieder	30/12/2017	2017-(123)-EN-OPA20171230-A14-B01-C01-NP-CD29_12.pdf
Kennisgeving FSMA of mededeling bieder	16/02/2018	2018-(123)-FR-NL-OPA20171230-A14-B01-C01-NP-CD15_02.pdf

Filter

OPA

Verrichting

Vrijwillige openbare overnameaanbieding

Effecten

Aandelen

Document

Kennisgevingen effectenverrichtingen

LEI

549300U4XEIPPXHC2L05

Company

Company	Company Type
Takeda Pharmaceutical Company	Bieder
TiGenix NV	Doelvenootschap OBA